title: [DRESS syndrome to sulfasalzine].
abstract: We report a case of drug hypersensibility syndrome (DRESS syndrome) developed one month after initiation of a treatment by sulfasalazine. Due to the severity of the cytolytic hepatic damages as observed in this case, we emphasize the importance of suggesting this diagnosis in any patient developing a cutaneous rash and an alteration of the general health status after initiation of a new treatment. The hematologic alterations which represent a key feature for the diagnosis may rash. develop only a few days after the cutaneous rash.
authors.affiliation: Service de Dermatologie, CHR Huy, Belgique.
authors.forename: R
authors.initials: R
authors.lastname: Bourguignon
authors.forename: C
authors.initials: C
authors.lastname: Piérrard-Franchimont
authors.forename: P
authors.initials: P
authors.lastname: Paquet
authors.forename: G E
authors.initials: GE
authors.lastname: Piérard
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D006801:Humans; D012460:Sulfasalazine / Q000009:adverse effects*; D013577:Syndrome
chemical_list: D018501:Antirheumatic Agents; D012460:Sulfasalazine